Loading...
Loading...
Browse all stories on DeepNewz
VisitOutcome of Starboard's campaign against Pfizer by end of 2024?
Albert Bourla steps down • 25%
Starboard gains board seats • 25%
No significant changes • 25%
Other outcomes • 25%
Official announcements from Pfizer or Starboard Value
Former Pfizer Executives Withdraw Support from Starboard's $1 Billion Activist Campaign Targeting Albert Bourla
Oct 10, 2024, 03:58 AM
Pfizer is currently facing activist pressure from Starboard Value, which has recently acquired $1 billion in Pfizer shares. The activist campaign has targeted Pfizer's CEO, Albert Bourla, criticizing the company's lack of focus, despite the company momentarily surpassing the $100 billion mark. However, in a surprising turn of events, former Pfizer executives Ian Read and Frank D'Amelio, who were initially associated with Starboard's efforts, have withdrawn their support for the campaign. They have publicly declared their full support for Bourla and the existing senior management team. Additionally, Pfizer's stock fell 1% following the announcement, and Starboard issued a letter to Pfizer’s board criticizing alleged coercive conduct towards former executives.
View original story
Starboard gains board seats • 25%
Starboard withdraws campaign • 25%
No significant changes • 25%
Other outcomes • 25%
Increased R&D investment • 25%
New product launches • 25%
Cost-cutting measures • 25%
Other strategic changes • 25%
Major restructuring • 25%
New strategic initiatives • 25%
Minor adjustments • 25%
No significant changes • 25%
Increases stake • 25%
Maintains stake • 25%
Reduces stake • 25%
Exits stake • 25%
Yes • 50%
No • 50%
Cost-cutting measures • 25%
New product focus • 25%
Management restructuring • 25%
Other • 25%
Board changes • 33%
Operational changes • 33%
No significant changes • 34%
No major changes • 25%
Major acquisition • 25%
Divestiture of a major division • 25%
Significant R&D pivot • 25%